Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Natco Pharma launches generic hepatitis C drug in India
BackBack

Natco Pharma launches generic hepatitis C drug in India

Natco Pharma launched a generic version of hepatitis C drug under the name 'Velpanat', says the company in a BSE filing

Natco priced its generic tablets at an MRP of Rs 18,500 for a bottle of 28 tablets in India. Photo: ReutersPremium
Natco priced its generic tablets at an MRP of Rs 18,500 for a bottle of 28 tablets in India. Photo: Reuters

New Delhi: Natco Pharma on Monday said it has launched generic sofosbuvir 400 mg/velpatasvir 100 mg tablets, used for treatment of chronic hepatitis C, in India.

The company has launched a generic version of sofosbuvir 400 mg/velpatasvir 100 mg fixed dose combination in India under the brand name ‘Velpanat’, Natco Pharma said in a BSE filing.

The company’s product is generic version of Gilead Sciences Inc’s Epclusa tablets. Epclusa is used to treat adults with chronic hepatitis C genotype 1 to 6 with or without cirrhosis, Natco Pharma said.

Natco priced its generic tablets at an MRP of 18,500 for a bottle of 28 tablets in India, the company said.

The company “has signed a non-exclusive licensing agreement with Gilead Sciences Inc to manufacture and sell generic versions of its chronic hepatitis C medicines in 101 developing countries, it added.

Shares of Natco Pharma were trading 0.77% up at 908.50 on BSE.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 08 May 2017, 01:55 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie